This week 5 new studies were published. We highlight 3 that include neuroimaging reviews, hypermobility and intracranial hypertension, and the economic cost of ME/CFS in Australia.
Tag: Australia
ME Awareness: Columbia University: Will there be a Post-COVID-19 form of ME/CFS? | 26 May 2020
“There is abundant evidence that ME/CFS can follow apparently infectious illnesses of uncertain cause, or a clearly diagnosed infectious illness…”
MEA Summary Review: Low Dose Naltrexone (LDN) in ME/CFS | 02 December 2019
We have updated this research review to include a new study from Finland.
Helpline Shop